Efficacy and safety of fenofibrate in combination with phototherapy for the treatment of neonatal hyperbilirubinemia: A systematic review and meta-analyses.
Canadian Journal of Physiology and Pharmacology · 2023
DOI: 10.1139/cjpp-2023-0213 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2023. Verfasst von Mohammed Abdellatif und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Muscat Private Hospital, Muscat, Oman. Hauptthemen laut MEDLINE: Fenofibrate, Hyperbilirubinemia, Neonatal, Phototherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Phototherapy is the standard treatment for neonatal jaundice. We aimed to review the efficacy and safety of fenofibrate as an adjunct therapy. Twelve databases were searched and a systematic review and meta-analysis were conducted. Mean change (MC), mean difference (MD), and risk ratios (RR) with a 95% confidence interval (CI) were calculated using a random effects model. The GRADE approach was used to evaluate the evidence's certainty. Nine randomized trials were included. The MC of total serum bilirubin (mg/dl) (TSB) was significant at 12, 24, 36, 48 and 72 hours with respective MC (95% CI) values of -0.46 (-0.61, -0.310), -1.10 (-1.68, -0.52), -2.06 (-2.20, -1.91), -2.15 (-2.74, -1.56), and -1.13 (-1.71, -0.55). The FEN+PT group had a shorter duration of phototherapy (MD -14.36 hours; 95% CI -23.67, -5.06) and a shorter hospital stay (MD: -1.40 days; 95% CI: -2.14, -0.66). There was no significant difference in the risk of complications (RR: 0.89; 95% CI: 0.54, 1.46) or the need for exchange transfusion (RR: 0.58; 95% CI: 0.12, 2.81). The certainty of the evidence was very low for all outcomes. In conclusion, fenofibrate might be a safe adjunct to neonatal phototherapy. Larger RCTs are needed for confirmation of these results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Muscat Private Hospital, Muscat, Oman.
- Online Research Club (www.onlineresearchclub.org), Nagasaki, Japan.
- Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Department of Pediatrics, Mount Sinai Hospital and University of Toronto, Toronto, Canada.
- Faculty of Medicine of Tunis, University of Tunis El Manar, Djebal Lakhdhar Street, 1006 Tunis, Tunisia.
- Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
ORCID-Profile: Mohammed Abdellatif, Ali Ahmed Fouad Abozaid, Prakesh S Shah, Nacir Dhouibi, Thuan Nguyen-Khac, Rafeef Khleif, Mai Ngoc Luu, Anton Mohareb, Gladson Vaghela, Zeeshan Ali Khan, Hoang Nhat Pham, Abdelrahman M Makram, Nguyen Tien Huy
Zitieren
APA
Abdellatif, M., Abozaid, A. A. F., Shah, P. S., Dhouibi, N., Nguyen-Khac, T., Khleif, R., Luu, M. N., Quyen, D. K., Mohareb, A., Vaghela, G., Khan, Z. A., Pham, H. N., Makram, A. M., & Huy, N. T. (2023). Efficacy and safety of fenofibrate in combination with phototherapy for the treatment of neonatal hyperbilirubinemia: A systematic review and meta-analyses. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0213
Vancouver
Abdellatif M, Abozaid AAF, Shah PS, Dhouibi N, Nguyen-Khac T, Khleif R, et al. Efficacy and safety of fenofibrate in combination with phototherapy for the treatment of neonatal hyperbilirubinemia: A systematic review and meta-analyses. Canadian Journal of Physiology and Pharmacology. 2023. doi:10.1139/cjpp-2023-0213
BibTeX
@article{Abdellatif2023,
author = {Abdellatif, Mohammed and Abozaid, Ali Ahmed Fouad and Shah, Prakesh S and Dhouibi, Nacir and Nguyen-Khac, Thuan and Khleif, Rafeef and Luu, Mai Ngoc and Quyen, Dinh Kim and Mohareb, Anton and Vaghela, Gladson and Khan, Zeeshan Ali and Pham, Hoang Nhat and Makram, Abdelrahman M and Huy, Nguyen Tien},
title = {Efficacy and safety of fenofibrate in combination with phototherapy for the treatment of neonatal hyperbilirubinemia: A systematic review and meta-analyses},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2023},
doi = {10.1139/cjpp-2023-0213}
}
EUVIMED